Shares of RTW Biotech Opportunities (LON:RTW – Get Free Report) traded up 0.7% on Friday . The stock traded as high as GBX 1.44 ($0.02) and last traded at GBX 1.40 ($0.02). 64,723 shares were traded during trading, a decline of 22% from the average session volume of 83,298 shares. The stock had previously closed at GBX 1.39 ($0.02).
RTW Biotech Opportunities Price Performance
The stock’s 50-day moving average price is GBX 1.47 and its 200-day moving average price is GBX 1.52. The company has a market cap of £4.70 million, a P/E ratio of 3.89 and a beta of 0.60.
About RTW Biotech Opportunities
RTW Biotech Opportunities Ltd (LSE: RTW or RTWG) is an investment fund focused on identifying transformative assets with high growth potential across the biopharmaceutical and medical technology sectors. Driven by a long-term approach to support innovative businesses, RTW Biotech Opportunities invests in companies developing next-generation therapies and technologies that can significantly improve patients’ lives.
Featured Articles
- Five stocks we like better than RTW Biotech Opportunities
- The Role Economic Reports Play in a Successful Investment Strategy
- Driving Forward: Lucid’s Growing Sales and Gravity SUV’s Impact
- The 3 Best Retail Stocks to Shop for in August
- Why Amazon’s Next Earnings Could Trigger a Stock Breakout
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- With This Kind of Data, The Fed Isn’t Cutting Rates This Year
Receive News & Ratings for RTW Biotech Opportunities Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTW Biotech Opportunities and related companies with MarketBeat.com's FREE daily email newsletter.
